 |
|
|
| |
8th European Conference on Clinical Aspects and treatment of HIV-Infection (ECCATHI)
Athens, Greece - October 2001 |
| |
| |
- One A Day Regimen for HIV: pilot study of FTC,ddI, efavirenz - Dec 3, 2001
- Summaries of Abstracts from the ECCATH - Meeting:
Hepatitis;
Interferon Monotherapy in HCV/HIV Coinfected Patients;
Body Changes in Italian Women: risk factors;
Drugs & the Liver;
Lipodystrophy & Metabolic Abnormalities: mitochondrial toxicity & NRTIs, fat cells;
Lipids & Medication Choices: the Atlantic Study;
HAART and the Heart
Written for NATAP by Graeme Moyle, MD, Chelsea & Westminster Medical Center, UK, London - Nov 27, 2001
- Hepatitis; Adverse Events(Lipodystrophy, hypersenstivity, hepatotoxicity,
bone problems, Newfill for lipoatrophy, clinical studies)
written by Mike Youle, MD, Royal Free Hospital, London, UK - Nov 13, 2001
- Indinavir + Ritonavir (800/100) vs Saquinavir + Ritonavir (1000/100), both twice daily - Nov 13, 2001
- Entry Inhibitors: T-20 (adults & children), T-1249 (early data in adults) - Nov 9, 2001
- Program Abstracts Presented by Tibotec/Virco at the 8th European Conference on Clinical Aspects and Treatment of HIV Infection (ECCATHI) in Athens, Greece - Nov 9, 2001
- Clinical data on the new extended release formulation of d4T - Oct 31, 2001
- Late phase II trial results of HIV fusion inhibitor T-20 appear promising - Oct 31, 2001
- Atazanavir Compared To Nelfinavir: 48 weeks - Oct 29, 2001
|
|
| |
|
|
|
|
|
